AUSTIN, Texas--(BUSINESS WIRE)--CynergisTek, (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity and information assurance, today announced that it has appointed Jon Hilfiger as the company’s new Senior Vice President of Sales and Marketing. Hilfiger brings more than twenty years of experience in global sales and business development to this role where he will lead client retention initiatives and drive new client acquisitions. Hilfiger will also provide strategic insights to support CynergisTek’s expansion of cybersecurity and managed services that meet the needs of the company’s clients.
Prior to CynergisTek, Hilfiger was the Vice President of Sales for PhishLabs, a global cybersecurity and digital risk protection firm, a position he held for more than five years. Before that, he spent over a decade at SecureWorks, where he held various roles that contributed to the company’s growth and successful acquisition by Dell in 2011. During his time there, Hilfiger led expansion efforts into new industries, driving growth at various Fortune 1000 accounts including healthcare and other critical industries.
“Jon brings a wealth of experience and knowledge to our executive leadership team and we are looking forward to him driving our marketing and sales efforts to new heights,” said Mac McMillan, CEO and President of CynergisTek. “Hilfiger’s cybersecurity and information security background and experience will be a valuable asset to the leadership team as our company seeks to accelerate its growth year after year. We’re thrilled to welcome Jon to the team.”
“I am excited to join CynergisTek, a company that has such a profound reputation for being the leader in information assurance and delivering superior services to its clients,” said Hilfiger. “I am looking forward to sharing my vast experiences and tapping into my deep security knowledge to continue to drive CynergisTek’s growth in the market and ensure continuous and optimal client support.”
Hilfiger will officially join CynergisTek as its Senior Vice President of Sales and Marketing on November 5, 2018.
About CynergisTek
CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, compliance, and document output goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity as well as the 2017 Best in KLAS winner for Cybersecurity Advisory Services.
Forward-Looking Statements
This release contains certain forward-looking statements relating to the business of CynergisTek that can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “may” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product/service development, long and uncertain sales cycles, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, future capital requirements, competition from other providers, the ability of our vendors to continue supplying the company with equipment, parts, supplies and services at comparable terms and prices and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
